Other
Change in Other Liabilities
Vertex Pharmaceuticals Change in Other Liabilities decreased by 78.2% to $23.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $22.00M to $23.10M. Over 3 years (FY 2021 to FY 2025), Change in Other Liabilities shows an upward trend with a 106.8% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026May 5, 2026
How to read this metric
Fluctuations are often driven by non-operating events or accounting adjustments rather than core business performance.
Detailed definition
This metric tracks the net change in miscellaneous short-term or long-term liabilities that are not classified as accoun...
Peer comparison
Standard line item in the cash flow statement for most large corporations.
Metric ID:
anet_change_in_other_liabilitiesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$54.30M | -$21.30M | $84.10M | $15.70M | -$47.40M | -$9.00M | $539.60M | $52.23M | $52.23M | $52.23M | $52.23M | $167.60M | -$256.60M | $134.10M | $22.00M | -$63.20M | $83.90M | $105.80M | $23.10M |
| QoQ Change | — | +60.8% | +494.8% | -81.3% | -401.9% | +81.0% | >999% | -90.3% | +0.0% | +0.0% | +0.0% | +220.9% | -253.1% | +152.3% | -83.6% | -387.3% | +232.8% | +26.1% | -78.2% |
| YoY Change | — | — | — | — | +12.7% | +57.7% | +541.6% | +232.6% | +210.2% | +680.3% | -90.3% | +220.9% | -591.3% | +156.8% | -86.9% | +75.4% | -37.4% | — | +5.0% |
Range-$256.60M – $539.60M
CAGR-17.3%
Avg YoY Growth+99.1%
Median YoY Growth+66.6%
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's change in other liabilities?
- Vertex Pharmaceuticals (VRTX) reported change in other liabilities of $23.10M in Q1 2026.
- How has Vertex Pharmaceuticals's change in other liabilities changed year-over-year?
- Vertex Pharmaceuticals's change in other liabilities increased by 5.0% year-over-year, from $22.00M to $23.10M.
- What is the long-term trend for Vertex Pharmaceuticals's change in other liabilities?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's change in other liabilities has grown at a 106.8% compound annual growth rate (CAGR), from $16.80M to $148.50M.
- What does change in other liabilities mean?
- The net change in miscellaneous liabilities not categorized elsewhere.